MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cholesterol drug shows promise in indian patients
Disease control CompletedThis study looked at how safe and effective the drug inclisiran is for Indian adults with high cholesterol or mixed dyslipidemia. Sixty-five participants received the drug as a shot under the skin. Researchers tracked side effects and measured how much LDL (bad) cholesterol dropp…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 08:55 UTC
-
New combo pill shows promise for stubborn high cholesterol
Disease control CompletedThis study tested whether a combination of two drugs (DW5421A and DW5421B) works better than one drug alone for lowering high cholesterol. 184 adults with high cholesterol or mixed lipid problems took part. The main goal was to see how much LDL (bad) cholesterol dropped after 8 w…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New drug shows promise for managing mixed dyslipidemia
Disease control CompletedThis study tested an experimental drug called plozasiran in 353 adults with mixed dyslipidemia, a condition with high triglycerides and cholesterol. Participants received either the drug or a placebo for 48 weeks while staying on a heart-healthy diet. The goal was to see if ploza…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
New injection shows promise for controlling blood fats
Disease control CompletedThis study tested an experimental drug called ARO-ANG3 in 204 adults with mixed dyslipidemia, a condition with high levels of fats like triglycerides and cholesterol in the blood. Participants received injections of the drug or a placebo to see if it safely lowers these fats. The…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Massive Real-World study checks cholesterol drugs in china
Knowledge-focused CompletedThis study looked at how well two cholesterol-lowering drugs, inclisiran and PCSK9 mAbs, work in real life for Chinese adults with high cholesterol. Researchers analyzed health records from nearly 12,000 patients across three databases. The goal was to see how much these drugs lo…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
New cholesterol drug tested in healthy adults – early safety results in
Knowledge-focused CompletedThis early-stage study tested a new drug called DW5124 in 55 healthy adults to see how safe it is and how the body processes it. Researchers also checked whether taking the drug with food changes its effects. The goal was to gather basic safety and drug-level information before t…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:36 UTC